Invest in ME has announced the latest fundraising total for the rituximab/B-cell research, which is a great boost as the research team at UCL are about to visit and discuss the subject with Dr Fluge and Professor Mella in Haukeland University Hospital, Bergen, Norway.
In order to build a trials protocol and identify likely responders a preliminary B-cell study has been underway at University College London. This will lead to the clinical trial.
In order to continue B-cell study research in ME, and as part of the overall research portfolio that Invest in ME has with UCL, they are committing themselves to fund a new PhD studentship at UCL beginning next year. This will augment the proposed Invest in ME rituximab clinical trial, will secure the longer term research into ME and will continue the relationship which IiME has built up with UCL.
New goal: £520,000
More info and how to donate